CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue:
Capitated revenue (Related parties comprised $0 and $128,394, in the three months ended June 30, 2022 and 2021, respectively, and $0 and $308,204, in the six months ended June 30, 2022 and 2021, respectively)	$ 655,493	$ 329,484	$ 1,329,844	$ 590,841
Fee-for-service and other revenue (Related parties comprised $0 and $219, in the three months ended June 30, 2022 and 2021, respectively, and $0 and $631, in the six months ended June 30, 2022 and 2021, respectively)	33,880	14,097	63,671	27,342
Total revenue	689,373	343,581	1,393,515	618,183
Operating expenses:
Third-party medical costs (Related parties comprised $0 and $115,975, in the three months ended June 30, 2022 and 2021, respectively, and $0 and $249,819, in the six months ended June 30, 2022 and 2021, respectively)	541,317	291,816	1,077,097	486,862
Direct patient expense (Related parties comprised $3,064 and $58, in the three months ended June 30, 2022 and 2021, respectively, and $4,518 and $1,488, in the six months ended June 30, 2022 and 2021, respectively)	52,647	35,607	113,323	69,844
Selling, general, and administrative expenses (Related parties comprised $3,305 and $1,840, in the three months ended June 30, 2022 and 2021, respectively, and $5,452 and $3,763, in the six months ended June 30, 2022 and 2021, respectively)	106,179	47,159	202,849	82,168
Depreciation and amortization expense	19,836	7,945	38,872	13,791
Transaction costs and other (Related parties comprised $0, $1,465, in the three months ended June 30, 2022 and 2021, respectively, and $0 and $1,483, in the six months ended June 30, 2022 and 2021, respectively)	6,207	16,114	14,583	25,068
Change in fair value of contingent consideration	(5,764)	(496)	(10,425)	(211)
Total operating expenses	720,422	398,145	1,436,299	677,522
Income (loss) from operations	(31,049)	(54,564)	(42,784)	(59,339)
Other income and expense:
Interest expense	(13,134)	(9,714)	(26,418)	(20,340)
Interest income	2	1	3	2
Loss on extinguishment of debt	0	(13,225)	(1,428)	(13,225)
Change in fair value of warrant liabilities	30,175	39,215	57,337	39,215
Other income (expenses)	251	(25)	530	(25)
Total other income	17,294	16,252	30,024	5,627
Net income (loss) before income tax expense	(13,755)	(38,312)	(12,760)	(53,712)
Income tax expense (benefit)	809	(2,023)	1,889	(1,309)
Net income (loss)	(14,564)	(36,289)	(14,649)	(52,403)
Net income (loss) attributable to non-controlling interests	(9,231)	(40,844)	(9,976)	(56,958)
Net income (loss) attributable to Class A common stockholders	$ (5,333)	$ 4,555	$ (4,673)	$ 4,555
Net income (loss) per share attributable to Class A common stockholders, basic (in dollars per share)	$ (0.03)	$ 0.03	$ (0.02)	$ 0.03
Net income (loss) per share attributable to Class A common stockholders, diluted (in dollars per share)	$ (0.03)	$ (0.06)	$ (0.03)	$ (0.06)
Weighted-average shares outstanding:
Basic (in shares)	210,053,037	167,134,853	200,783,129	166,691,634
Diluted (in shares)	474,580,471	168,884,315	465,310,563	167,571,198